Ticker: STOK

Company: Stoke Therapeutics, Inc.

Person: Jonathan Allan, officer

Transaction date: Dec. 1, 2025

Reporting date: Dec. 3, 2025

Average share price: -17.769975453026603

Sold 7781.0 shares for 138268.18